Sai Life Sciences Limited (NSE:SAILIFE)
India flag India · Delayed Price · Currency is INR
1,798.30
-130.50 (-6.77%)
Nov 16, 2026, 3:00 PM IST

Sai Life Sciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
3,7623,4891,701828.0999.8962.26
Depreciation & Amortization
1,7491,5831,2901,107948.59869.2
Other Amortization
85.5285.5296.1987.6745.7332.41
Loss (Gain) From Sale of Assets
6.49.6318.11-0.15.67-113.15
Asset Writedown & Restructuring Costs
-1.70.4917.261.86--
Loss (Gain) From Sale of Investments
-19.74-4.92----
Stock-Based Compensation
30.1721.0424.7822.538.1422.41
Provision & Write-off of Bad Debts
-313.81-249.35309.0977.9479.4861.16
Other Operating Activities
1,203894.74995.14828.61657.27359.87
Change in Accounts Receivable
1,408-154.17-999.65288.14-450.79-432.45
Change in Inventory
-1,198-321.03-314.22520.87-126.17-505.64
Change in Accounts Payable
367.37327.091,059-700.51123.85642.96
Change in Other Net Operating Assets
-1,014-589.84-1,056-490.92802.3749.63
Operating Cash Flow
6,0645,0913,1402,6312,1941,049
Operating Cash Flow Growth
98.49%62.12%19.37%19.91%109.22%-

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-9,066-5,930-3,693-1,817-1,131-2,069
Sale of Property, Plant & Equipment
12.185.184.778.53419.07985.42
Investment in Securities
-1,160-1,176-20.75950-368.525
Other Investing Activities
833.753,146-1,658-1,06562.3941.58
Investing Cash Flow
-9,380-3,954-5,367-1,924-1,018-1,037

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
---248.93-739.39
Long-Term Debt Issued
-255.04534.087503001,001
Total Debt Issued
2,981255.04534.08998.933001,741
Short-Term Debt Repaid
-----664.36-
Long-Term Debt Repaid
--1,204-6,749-1,108-877.99-552.2
Lease Payments
-654.11-615.52-510.64-441.05-345.23-235.95
Total Debt Repaid
-1,306-1,204-6,749-1,108-1,542-552.2
Net Debt Issued (Repaid)
1,676-949.38-6,215-109.4-1,2421,189
Issuance of Common Stock
258.52250.9410,1169.6720.9131.25
Other Financing Activities
-368.56-538.36-887.31-853.26-785.04-500.69
Financing Cash Flow
1,566-1,2373,014-952.99-2,006719.23

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-17.958.22.7810.3327.820.75
Net Cash Flow
-1,768-91.38790.83-235.6-802.46751.5

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-3,002-838.28-552.35813.971,063-1,020
Free Cash Flow Growth
----23.45%--
Free Cash Flow Margin
-12.66%-3.82%-3.26%5.56%8.74%-11.73%
Free Cash Flow Per Share
-14.08-3.95-2.794.455.83-5.62
Levered Free Cash Flow
-3,630-847.87-1,889-254.98-19.44-2,056
Unlevered Free Cash Flow
-3,404-602.63-1,413281.96462.16-1,746
Free Cash Flow After Leases
-3,656-1,454-1,063372.92718.05-1,256

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
374.08339.87774.11853.26785.04500.69
Cash Income Tax Paid
341.18389.27216.31138.7340.881.23
Change in Working Capital
-436.3-737.95-1,311-382.42349.26-245.5